Gene Symbol | Gene ID | Gene Info |
---|---|---|
SPIC
|
ENSG00000166211.6 | Spi-C transcription factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_101878998_101879149 | SPIC | 8416 | 0.144694 | 0.62 | 7.8e-02 | Click! |
chr12_101873240_101873391 | SPIC | 2658 | 0.202535 | 0.58 | 9.8e-02 | Click! |
chr12_101884070_101884221 | SPIC | 13488 | 0.139424 | 0.58 | 1.0e-01 | Click! |
chr12_101880395_101880546 | SPIC | 9813 | 0.142772 | 0.49 | 1.8e-01 | Click! |
chr12_101873879_101874030 | SPIC | 3297 | 0.180788 | 0.47 | 2.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_50181859_50182149 | 3.62 |
ARL11 |
ADP-ribosylation factor-like 11 |
20431 |
0.18 |
chr12_7596853_7597078 | 3.45 |
CD163L1 |
CD163 molecule-like 1 |
184 |
0.96 |
chr10_104498654_104499163 | 3.34 |
WBP1L |
WW domain binding protein 1-like |
4819 |
0.16 |
chr10_129959144_129959646 | 3.32 |
MKI67 |
marker of proliferation Ki-67 |
34746 |
0.23 |
chr16_67702806_67703065 | 3.27 |
C16orf86 |
chromosome 16 open reading frame 86 |
2142 |
0.15 |
chr2_210850558_210850852 | 3.14 |
RPE |
ribulose-5-phosphate-3-epimerase |
16584 |
0.17 |
chr2_40701476_40701669 | 3.13 |
SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
20994 |
0.29 |
chr12_14711116_14711409 | 2.93 |
PLBD1 |
phospholipase B domain containing 1 |
4082 |
0.17 |
chr1_64978255_64978644 | 2.92 |
CACHD1 |
cache domain containing 1 |
41974 |
0.18 |
chr7_124483399_124483792 | 2.91 |
POT1 |
protection of telomeres 1 |
709 |
0.78 |
chr7_50320921_50321337 | 2.91 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
23195 |
0.25 |
chr22_24845274_24845662 | 2.87 |
ADORA2A |
adenosine A2a receptor |
16660 |
0.15 |
chr13_77324338_77324489 | 2.87 |
KCTD12 |
potassium channel tetramerization domain containing 12 |
136112 |
0.05 |
chr10_94217216_94217411 | 2.83 |
ENSG00000207895 |
. |
16252 |
0.21 |
chr9_123983233_123983631 | 2.79 |
RAB14 |
RAB14, member RAS oncogene family |
1860 |
0.29 |
chr15_67158530_67158864 | 2.77 |
SMAD6 |
SMAD family member 6 |
154662 |
0.04 |
chr5_124049375_124049549 | 2.76 |
RP11-436H11.2 |
|
15062 |
0.13 |
chr3_72129424_72129793 | 2.76 |
ENSG00000212070 |
. |
181971 |
0.03 |
chr2_99271555_99271876 | 2.75 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
8221 |
0.22 |
chr1_150747520_150747793 | 2.75 |
CTSS |
cathepsin S |
9223 |
0.13 |
chr14_51392674_51392825 | 2.66 |
RP11-218E20.5 |
|
13805 |
0.16 |
chr4_40350204_40350355 | 2.65 |
CHRNA9 |
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
12933 |
0.2 |
chr10_111878775_111878926 | 2.60 |
MXI1 |
MAX interactor 1, dimerization protein |
88513 |
0.08 |
chr12_10204798_10205132 | 2.60 |
CLEC9A |
C-type lectin domain family 9, member A |
21689 |
0.1 |
chr3_160690829_160691249 | 2.58 |
B3GALNT1 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
127916 |
0.05 |
chr2_192301147_192301752 | 2.56 |
MYO1B |
myosin IB |
25658 |
0.23 |
chr8_48318969_48319120 | 2.51 |
SPIDR |
scaffolding protein involved in DNA repair |
33919 |
0.22 |
chr1_169229043_169229527 | 2.50 |
RP4-800F24.1 |
|
50618 |
0.14 |
chr7_37354921_37355641 | 2.48 |
ELMO1 |
engulfment and cell motility 1 |
27086 |
0.19 |
chr3_72523180_72523331 | 2.46 |
RYBP |
RING1 and YY1 binding protein |
27186 |
0.23 |
chr5_142497345_142497691 | 2.43 |
ARHGAP26 |
Rho GTPase activating protein 26 |
61870 |
0.14 |
chr1_223850651_223850854 | 2.43 |
CAPN8 |
calpain 8 |
2596 |
0.3 |
chr4_75955696_75956116 | 2.43 |
RP11-44F21.2 |
|
4128 |
0.31 |
chr2_68597035_68597533 | 2.42 |
AC015969.3 |
|
4568 |
0.19 |
chr12_11748797_11749209 | 2.42 |
ENSG00000251747 |
. |
49590 |
0.13 |
chrX_109132554_109132705 | 2.42 |
TMEM164 |
transmembrane protein 164 |
113234 |
0.06 |
chr10_98464854_98465114 | 2.40 |
PIK3AP1 |
phosphoinositide-3-kinase adaptor protein 1 |
15287 |
0.2 |
chr13_110308405_110308649 | 2.40 |
LINC00676 |
long intergenic non-protein coding RNA 676 |
72102 |
0.13 |
chr13_78299657_78299947 | 2.38 |
SLAIN1 |
SLAIN motif family, member 1 |
6069 |
0.24 |
chr1_108457163_108457314 | 2.38 |
VAV3-AS1 |
VAV3 antisense RNA 1 |
49827 |
0.14 |
chr10_7124084_7124395 | 2.35 |
SFMBT2 |
Scm-like with four mbt domains 2 |
326468 |
0.01 |
chr9_6890051_6890228 | 2.35 |
RP11-403H13.1 |
|
12531 |
0.25 |
chr6_109162800_109163213 | 2.33 |
ARMC2 |
armadillo repeat containing 2 |
6613 |
0.28 |
chr18_9702219_9702424 | 2.31 |
RAB31 |
RAB31, member RAS oncogene family |
5841 |
0.24 |
chr15_39760556_39760958 | 2.30 |
RP11-624L4.1 |
|
41361 |
0.18 |
chr22_24915470_24915848 | 2.30 |
AP000355.2 |
|
3183 |
0.18 |
chr6_137567831_137568175 | 2.30 |
IFNGR1 |
interferon gamma receptor 1 |
27417 |
0.23 |
chr1_202957021_202957552 | 2.29 |
RP11-38O14.5 |
|
424 |
0.76 |
chr6_136931541_136931692 | 2.28 |
RP3-325F22.3 |
|
18694 |
0.15 |
chr13_46747571_46748374 | 2.28 |
ENSG00000240767 |
. |
4089 |
0.19 |
chr14_65509694_65510092 | 2.25 |
ENSG00000266531 |
. |
1513 |
0.32 |
chr2_219057742_219057958 | 2.25 |
ENSG00000238428 |
. |
8045 |
0.13 |
chr6_16092423_16092777 | 2.24 |
MYLIP |
myosin regulatory light chain interacting protein |
36756 |
0.16 |
chr14_75150069_75150405 | 2.23 |
AREL1 |
apoptosis resistant E3 ubiquitin protein ligase 1 |
7319 |
0.16 |
chr2_160711825_160711976 | 2.22 |
LY75 |
lymphocyte antigen 75 |
49293 |
0.13 |
chr7_20510389_20510674 | 2.21 |
ENSG00000200753 |
. |
93577 |
0.08 |
chr1_234661335_234661635 | 2.21 |
TARBP1 |
TAR (HIV-1) RNA binding protein 1 |
46636 |
0.13 |
chr2_15260083_15260395 | 2.20 |
NBAS |
neuroblastoma amplified sequence |
70282 |
0.14 |
chr7_69837519_69837796 | 2.19 |
AUTS2 |
autism susceptibility candidate 2 |
356468 |
0.01 |
chrX_147365446_147365792 | 2.19 |
AC002368.4 |
|
216516 |
0.02 |
chr7_139587769_139587986 | 2.18 |
TBXAS1 |
thromboxane A synthase 1 (platelet) |
58767 |
0.14 |
chr3_196322790_196323004 | 2.17 |
FBXO45 |
F-box protein 45 |
27338 |
0.1 |
chr12_52085972_52086211 | 2.17 |
SCN8A |
sodium channel, voltage gated, type VIII, alpha subunit |
5884 |
0.28 |
chrX_65270014_65270332 | 2.16 |
VSIG4 |
V-set and immunoglobulin domain containing 4 |
10206 |
0.23 |
chr1_58717564_58717715 | 2.16 |
DAB1 |
Dab, reelin signal transducer, homolog 1 (Drosophila) |
1428 |
0.6 |
chr20_39919427_39919896 | 2.16 |
ENSG00000263989 |
. |
444 |
0.84 |
chrX_4171213_4171579 | 2.16 |
ENSG00000264861 |
. |
330145 |
0.01 |
chr1_172485166_172485402 | 2.16 |
SUCO |
SUN domain containing ossification factor |
16205 |
0.21 |
chr2_171807097_171807248 | 2.14 |
GORASP2 |
golgi reassembly stacking protein 2, 55kDa |
21341 |
0.2 |
chr6_167131669_167131892 | 2.14 |
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
39619 |
0.19 |
chr18_32827902_32828053 | 2.13 |
ZNF397 |
zinc finger protein 397 |
5540 |
0.24 |
chr1_221249282_221249543 | 2.13 |
HLX |
H2.0-like homeobox |
194828 |
0.03 |
chr20_1517766_1518008 | 2.12 |
ENSG00000252103 |
. |
8082 |
0.14 |
chr7_132338217_132338396 | 2.10 |
AC009365.3 |
|
4753 |
0.24 |
chr12_121136719_121136994 | 2.10 |
RP11-173P15.3 |
|
448 |
0.69 |
chr6_14947745_14947999 | 2.09 |
ENSG00000242989 |
. |
165327 |
0.04 |
chr19_15752857_15753008 | 2.09 |
CYP4F3 |
cytochrome P450, family 4, subfamily F, polypeptide 3 |
813 |
0.62 |
chr4_74713278_74713440 | 2.09 |
PPBPP1 |
pro-platelet basic protein pseudogene 1 |
224 |
0.91 |
chr1_229159365_229159528 | 2.09 |
RP5-1061H20.5 |
|
203863 |
0.02 |
chr3_4517464_4517729 | 2.08 |
SUMF1 |
sulfatase modifying factor 1 |
8631 |
0.21 |
chr7_132338418_132338569 | 2.07 |
AC009365.3 |
|
4940 |
0.24 |
chr10_94438085_94438236 | 2.06 |
HHEX |
hematopoietically expressed homeobox |
9785 |
0.19 |
chr3_137855166_137855317 | 2.06 |
A4GNT |
alpha-1,4-N-acetylglucosaminyltransferase |
4012 |
0.22 |
chr5_67306686_67306837 | 2.05 |
ENSG00000223149 |
. |
43488 |
0.2 |
chr9_92140839_92141158 | 2.05 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
27953 |
0.19 |
chr1_65329902_65330534 | 2.05 |
RAVER2 |
ribonucleoprotein, PTB-binding 2 |
86471 |
0.09 |
chr7_41747683_41748187 | 2.05 |
AC005027.3 |
|
3002 |
0.27 |
chr5_127175889_127176216 | 2.04 |
CTC-548H10.2 |
|
176331 |
0.03 |
chrX_19915221_19915598 | 2.04 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
9690 |
0.25 |
chr9_80551026_80551177 | 2.04 |
GNAQ |
guanine nucleotide binding protein (G protein), q polypeptide |
94419 |
0.09 |
chr17_29701155_29701367 | 2.04 |
NF1 |
neurofibromin 1 |
15695 |
0.14 |
chr15_90506772_90506923 | 2.03 |
ZNF710 |
zinc finger protein 710 |
37777 |
0.09 |
chr5_34048003_34048156 | 2.02 |
C1QTNF3 |
C1q and tumor necrosis factor related protein 3 |
4142 |
0.26 |
chr8_60247884_60248322 | 2.02 |
ENSG00000201763 |
. |
120341 |
0.06 |
chr16_31255453_31255604 | 2.01 |
ITGAM |
integrin, alpha M (complement component 3 receptor 3 subunit) |
15783 |
0.08 |
chr12_67086032_67086183 | 2.01 |
GRIP1 |
glutamate receptor interacting protein 1 |
13182 |
0.31 |
chr15_50359578_50359751 | 2.01 |
ATP8B4 |
ATPase, class I, type 8B, member 4 |
20080 |
0.22 |
chr16_16101776_16101984 | 2.01 |
ABCC1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
1833 |
0.43 |
chr21_39862698_39862878 | 2.00 |
ERG |
v-ets avian erythroblastosis virus E26 oncogene homolog |
7557 |
0.32 |
chr5_138531999_138532442 | 2.00 |
SIL1 |
SIL1 nucleotide exchange factor |
10 |
0.98 |
chr6_20475082_20475359 | 2.00 |
ENSG00000222431 |
. |
22516 |
0.14 |
chrX_71799270_71799421 | 1.99 |
HDAC8 |
histone deacetylase 8 |
6392 |
0.27 |
chr6_116950762_116950913 | 1.99 |
RSPH4A |
radial spoke head 4 homolog A (Chlamydomonas) |
13050 |
0.16 |
chr1_168490081_168490873 | 1.99 |
XCL2 |
chemokine (C motif) ligand 2 |
22758 |
0.22 |
chr9_90169942_90170331 | 1.98 |
DAPK1-IT1 |
DAPK1 intronic transcript 1 (non-protein coding) |
1767 |
0.46 |
chr18_11002886_11003122 | 1.98 |
RP11-513M1.1 |
|
109389 |
0.07 |
chrX_65225891_65226383 | 1.98 |
RP6-159A1.3 |
|
6544 |
0.22 |
chr11_59483254_59483676 | 1.98 |
OR10V1 |
olfactory receptor, family 10, subfamily V, member 1 |
2128 |
0.2 |
chr3_112276908_112277390 | 1.97 |
SLC35A5 |
solute carrier family 35, member A5 |
3407 |
0.23 |
chr10_8173315_8173777 | 1.97 |
GATA3 |
GATA binding protein 3 |
76777 |
0.12 |
chr2_232557857_232558041 | 1.97 |
MGC4771 |
|
13672 |
0.16 |
chr1_213447364_213447603 | 1.96 |
RPS6KC1 |
ribosomal protein S6 kinase, 52kDa, polypeptide 1 |
222879 |
0.02 |
chr12_4300198_4300468 | 1.95 |
CCND2 |
cyclin D2 |
82605 |
0.08 |
chr16_55478940_55479091 | 1.95 |
MMP2 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
33727 |
0.18 |
chr11_127345243_127345408 | 1.95 |
ENSG00000223315 |
. |
67579 |
0.13 |
chr8_97824052_97824283 | 1.94 |
CPQ |
carboxypeptidase Q |
50699 |
0.18 |
chr9_19931077_19931322 | 1.94 |
ENSG00000266224 |
. |
101448 |
0.08 |
chr11_59831605_59831852 | 1.94 |
MS4A3 |
membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) |
3094 |
0.24 |
chr20_23635464_23635615 | 1.94 |
CST3 |
cystatin C |
16429 |
0.17 |
chr8_8308239_8308687 | 1.93 |
SGK223 |
Tyrosine-protein kinase SgK223 |
64455 |
0.12 |
chr8_144432942_144433093 | 1.93 |
ENSG00000212221 |
. |
675 |
0.52 |
chr10_30876556_30876825 | 1.92 |
ENSG00000239744 |
. |
31857 |
0.18 |
chr2_46071010_46071516 | 1.91 |
PRKCE |
protein kinase C, epsilon |
156778 |
0.04 |
chr6_137180665_137180816 | 1.91 |
ENSG00000201807 |
. |
3771 |
0.24 |
chrX_108863273_108863559 | 1.91 |
KCNE1L |
KCNE1-like |
4977 |
0.28 |
chr1_204468090_204468417 | 1.91 |
PIK3C2B |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
4401 |
0.21 |
chr2_231361368_231362080 | 1.91 |
SP100 |
SP100 nuclear antigen |
7253 |
0.21 |
chr17_62153274_62153425 | 1.91 |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
54136 |
0.09 |
chr2_68919813_68920004 | 1.90 |
ARHGAP25 |
Rho GTPase activating protein 25 |
17726 |
0.22 |
chr2_99350910_99351516 | 1.90 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
3624 |
0.28 |
chr1_93569209_93569360 | 1.90 |
MTF2 |
metal response element binding transcription factor 2 |
24416 |
0.16 |
chr11_14561946_14562368 | 1.89 |
PSMA1 |
proteasome (prosome, macropain) subunit, alpha type, 1 |
19915 |
0.2 |
chr1_113524173_113524422 | 1.89 |
SLC16A1 |
solute carrier family 16 (monocarboxylate transporter), member 1 |
24662 |
0.19 |
chr2_233083878_233084231 | 1.89 |
ENSG00000207626 |
. |
46691 |
0.14 |
chr8_87139227_87139463 | 1.88 |
CTD-3118D11.2 |
|
27090 |
0.16 |
chr17_434522_434673 | 1.88 |
RP5-1029F21.4 |
|
8217 |
0.18 |
chr6_51778152_51778400 | 1.88 |
ENSG00000240641 |
. |
62182 |
0.14 |
chr11_76569492_76569643 | 1.88 |
ACER3 |
alkaline ceramidase 3 |
2344 |
0.27 |
chr10_11257130_11257986 | 1.88 |
RP3-323N1.2 |
|
44219 |
0.16 |
chr18_60617582_60618139 | 1.88 |
PHLPP1 |
PH domain and leucine rich repeat protein phosphatase 1 |
47477 |
0.17 |
chr12_94519842_94520141 | 1.87 |
PLXNC1 |
plexin C1 |
22508 |
0.21 |
chr6_143023274_143023425 | 1.87 |
RP1-67K17.3 |
|
46231 |
0.19 |
chr9_27628423_27628574 | 1.86 |
C9orf72 |
chromosome 9 open reading frame 72 |
54634 |
0.15 |
chr2_112758544_112758832 | 1.86 |
MERTK |
c-mer proto-oncogene tyrosine kinase |
18302 |
0.21 |
chr17_8856804_8857368 | 1.86 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
11938 |
0.24 |
chr12_123412300_123412568 | 1.86 |
ABCB9 |
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
16785 |
0.14 |
chr8_65729484_65729641 | 1.86 |
CYP7B1 |
cytochrome P450, family 7, subfamily B, polypeptide 1 |
18244 |
0.27 |
chr15_85547335_85547486 | 1.86 |
PDE8A |
phosphodiesterase 8A |
22198 |
0.18 |
chr11_104893890_104894087 | 1.85 |
CASP5 |
caspase 5, apoptosis-related cysteine peptidase |
93 |
0.97 |
chr13_72381125_72381331 | 1.85 |
DACH1 |
dachshund homolog 1 (Drosophila) |
59679 |
0.16 |
chr5_39267718_39267869 | 1.84 |
FYB |
FYN binding protein |
2953 |
0.37 |
chr15_75195081_75195345 | 1.84 |
CTD-2235H24.2 |
|
2880 |
0.15 |
chr12_109103146_109103401 | 1.83 |
CORO1C |
coronin, actin binding protein, 1C |
6422 |
0.17 |
chr9_93557450_93557605 | 1.83 |
SYK |
spleen tyrosine kinase |
6542 |
0.34 |
chr11_66882952_66883149 | 1.83 |
KDM2A |
lysine (K)-specific demethylase 2A |
3690 |
0.21 |
chr9_102353254_102353422 | 1.83 |
NR4A3 |
nuclear receptor subfamily 4, group A, member 3 |
230799 |
0.02 |
chr3_148477195_148477534 | 1.82 |
AGTR1 |
angiotensin II receptor, type 1 |
19779 |
0.22 |
chr2_219951077_219951453 | 1.82 |
ENSG00000240317 |
. |
15891 |
0.1 |
chr10_23031522_23031808 | 1.82 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
28181 |
0.21 |
chr16_15687209_15687510 | 1.82 |
CTB-193M12.1 |
|
14972 |
0.15 |
chr17_74102777_74103137 | 1.82 |
EXOC7 |
exocyst complex component 7 |
3089 |
0.15 |
chr11_128515950_128516456 | 1.82 |
RP11-744N12.3 |
|
40120 |
0.13 |
chr1_226202818_226203071 | 1.82 |
SDE2 |
SDE2 telomere maintenance homolog (S. pombe) |
15912 |
0.15 |
chr14_50704212_50704488 | 1.82 |
SOS2 |
son of sevenless homolog 2 (Drosophila) |
6074 |
0.21 |
chr3_53192591_53193057 | 1.81 |
PRKCD |
protein kinase C, delta |
2312 |
0.27 |
chr5_58552045_58552338 | 1.81 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
19754 |
0.29 |
chr2_233946710_233947120 | 1.81 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
21726 |
0.18 |
chr20_19051967_19052205 | 1.81 |
ENSG00000264669 |
. |
54343 |
0.15 |
chr6_152473193_152473462 | 1.81 |
SYNE1 |
spectrin repeat containing, nuclear envelope 1 |
16159 |
0.29 |
chr19_42291510_42291673 | 1.80 |
AC011513.4 |
|
790 |
0.52 |
chr1_184793873_184794024 | 1.80 |
ENSG00000252222 |
. |
3325 |
0.28 |
chr3_184395925_184396214 | 1.80 |
MAGEF1 |
melanoma antigen family F, 1 |
33767 |
0.19 |
chr10_73563933_73564084 | 1.79 |
CDH23 |
cadherin-related 23 |
8480 |
0.18 |
chr17_29281218_29281504 | 1.79 |
AC091177.1 |
|
2618 |
0.14 |
chr17_20003497_20003738 | 1.79 |
SPECC1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
4611 |
0.24 |
chr17_55063100_55063251 | 1.79 |
RP5-1107A17.4 |
|
3065 |
0.17 |
chr7_7907818_7908119 | 1.79 |
ENSG00000201747 |
. |
38182 |
0.17 |
chr3_154673966_154674117 | 1.78 |
MME |
membrane metallo-endopeptidase |
67872 |
0.14 |
chr6_119085437_119085683 | 1.78 |
CEP85L |
centrosomal protein 85kDa-like |
54322 |
0.14 |
chr20_48417310_48417498 | 1.78 |
ENSG00000252540 |
. |
6056 |
0.17 |
chr4_184752866_184753040 | 1.78 |
STOX2 |
storkhead box 2 |
73556 |
0.1 |
chr1_153409364_153409536 | 1.77 |
S100A7L2 |
S100 calcium binding protein A7-like 2 |
2975 |
0.15 |
chr14_75662934_75663411 | 1.77 |
ENSG00000252013 |
. |
5700 |
0.17 |
chr2_152692120_152692290 | 1.77 |
ARL5A |
ADP-ribosylation factor-like 5A |
7203 |
0.3 |
chr10_89805293_89806077 | 1.77 |
ENSG00000200891 |
. |
51233 |
0.16 |
chr7_50350050_50350273 | 1.77 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
1843 |
0.48 |
chr8_67664915_67665066 | 1.77 |
SGK3 |
serum/glucocorticoid regulated kinase family, member 3 |
22459 |
0.18 |
chr8_116890545_116890696 | 1.76 |
TRPS1 |
trichorhinophalangeal syndrome I |
68721 |
0.14 |
chr1_61415367_61415638 | 1.76 |
RP4-668G5.1 |
|
3019 |
0.37 |
chrX_46693863_46694266 | 1.76 |
RP2 |
retinitis pigmentosa 2 (X-linked recessive) |
2311 |
0.35 |
chr2_48689029_48689283 | 1.76 |
PPP1R21 |
protein phosphatase 1, regulatory subunit 21 |
20888 |
0.19 |
chr15_80192571_80192722 | 1.76 |
MTHFS |
5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase) |
3255 |
0.2 |
chr12_10247211_10247429 | 1.76 |
CLEC1A |
C-type lectin domain family 1, member A |
4229 |
0.15 |
chr20_8380540_8381084 | 1.76 |
PLCB1-IT1 |
PLCB1 intronic transcript 1 (non-protein coding) |
151440 |
0.04 |
chr14_75795544_75795840 | 1.76 |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
48796 |
0.11 |
chr17_68674457_68674692 | 1.75 |
KCNJ2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
508898 |
0.0 |
chr1_160987971_160988369 | 1.75 |
F11R |
F11 receptor |
2716 |
0.15 |
chr12_2473504_2473665 | 1.75 |
CACNA1C-IT3 |
CACNA1C intronic transcript 3 (non-protein coding) |
94642 |
0.08 |
chr20_9175560_9175901 | 1.75 |
PLCB4 |
phospholipase C, beta 4 |
22307 |
0.27 |
chr6_14898152_14898303 | 1.75 |
ENSG00000242989 |
. |
214972 |
0.02 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 6.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.0 | 3.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.0 | 3.0 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.9 | 2.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.9 | 3.7 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.9 | 2.6 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.9 | 0.9 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.8 | 2.5 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.8 | 2.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.8 | 2.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.8 | 0.8 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
0.7 | 0.7 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.7 | 2.2 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.7 | 2.2 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.7 | 1.4 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.7 | 2.1 | GO:0010193 | response to ozone(GO:0010193) |
0.7 | 2.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.7 | 1.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.7 | 3.3 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.6 | 1.9 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.6 | 1.9 | GO:0032661 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.6 | 1.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.6 | 4.1 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.6 | 2.3 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.6 | 1.7 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.6 | 1.7 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.6 | 1.7 | GO:0071436 | sodium ion export(GO:0071436) |
0.6 | 1.7 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 1.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.5 | 1.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.5 | 2.6 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.5 | 0.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.5 | 2.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.5 | 2.5 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.5 | 1.0 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.5 | 1.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 1.5 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.5 | 4.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.5 | 0.5 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.5 | 1.5 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 0.5 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.5 | 1.0 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.5 | 2.0 | GO:0043049 | otic placode formation(GO:0043049) |
0.5 | 2.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.5 | 0.5 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.5 | 0.5 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.5 | 4.3 | GO:0042119 | neutrophil activation(GO:0042119) |
0.5 | 0.9 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.5 | 0.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 | 6.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.5 | 1.9 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 0.9 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.5 | 1.4 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.5 | 3.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.5 | 1.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 0.9 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.4 | 1.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 6.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.4 | 1.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.4 | 3.0 | GO:0031060 | regulation of histone methylation(GO:0031060) |
0.4 | 2.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 1.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.4 | 1.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.4 | 1.3 | GO:0001821 | histamine secretion(GO:0001821) |
0.4 | 0.4 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 0.4 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.4 | 1.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.4 | 1.2 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.4 | 0.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.4 | 1.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 1.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.4 | 1.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.4 | 0.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 1.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.4 | 2.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 0.4 | GO:0070265 | necrotic cell death(GO:0070265) |
0.4 | 1.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 5.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 1.2 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.4 | 0.8 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.4 | 1.5 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.4 | 2.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.4 | 0.8 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.4 | 1.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.4 | 1.5 | GO:0045056 | transcytosis(GO:0045056) |
0.4 | 0.8 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.4 | 0.8 | GO:0002666 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.4 | 3.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 0.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.4 | 0.7 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.4 | 1.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 1.5 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.4 | 0.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.4 | 0.4 | GO:0050755 | chemokine biosynthetic process(GO:0042033) positive regulation of chemokine biosynthetic process(GO:0045080) chemokine metabolic process(GO:0050755) |
0.4 | 0.4 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.4 | 1.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 0.7 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.4 | 1.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.4 | 1.1 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.4 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) sodium ion homeostasis(GO:0055078) |
0.4 | 1.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.3 | 0.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.3 | 1.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.3 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.3 | 1.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.3 | 1.7 | GO:0002532 | production of molecular mediator involved in inflammatory response(GO:0002532) |
0.3 | 2.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 0.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 1.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.3 | 0.3 | GO:0036230 | granulocyte activation(GO:0036230) |
0.3 | 0.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.3 | 1.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.3 | 0.3 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 2.6 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.3 | 1.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.3 | 0.7 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.3 | 1.0 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.3 | 1.9 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 1.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 0.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.3 | 0.3 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.3 | 1.3 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 0.6 | GO:0048143 | astrocyte activation(GO:0048143) |
0.3 | 2.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.3 | 0.6 | GO:0045980 | negative regulation of nucleotide metabolic process(GO:0045980) |
0.3 | 1.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.3 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.3 | 2.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.3 | 0.9 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.3 | 1.8 | GO:0015904 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.3 | 0.3 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.3 | 0.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 0.3 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.3 | 0.9 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.3 | 0.6 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.3 | 0.6 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.3 | 1.2 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 0.6 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 0.6 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.3 | 1.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.3 | 1.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 1.4 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.3 | 0.6 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.3 | 1.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 0.8 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 0.3 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.3 | 0.6 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.3 | 4.1 | GO:0071554 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.3 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 0.8 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.3 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 4.6 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.3 | 0.8 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.3 | 1.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.3 | 0.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 1.6 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.3 | 1.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.3 | 0.3 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.3 | 0.8 | GO:0015669 | gas transport(GO:0015669) |
0.3 | 0.8 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.3 | 1.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 1.8 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.3 | 2.5 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.3 | 0.3 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) |
0.3 | 0.5 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.3 | 0.8 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 0.7 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.5 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.2 | 0.2 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.2 | 2.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.2 | 0.2 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.2 | 1.2 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.5 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.2 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 1.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 0.7 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 0.2 | GO:1902622 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.2 | 1.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.2 | GO:0014826 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) vein smooth muscle contraction(GO:0014826) |
0.2 | 0.7 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 0.2 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.2 | 0.7 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 2.1 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.2 | 0.9 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 0.7 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 0.5 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.2 | 1.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.2 | 0.9 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.7 | GO:0046618 | drug export(GO:0046618) |
0.2 | 0.9 | GO:0042116 | macrophage activation(GO:0042116) |
0.2 | 0.9 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.7 | GO:0046886 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.2 | 1.8 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.2 | 3.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 2.0 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.2 | 0.7 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.5 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.2 | 1.1 | GO:0045217 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.2 | 0.4 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.2 | 0.7 | GO:1903224 | endodermal cell fate commitment(GO:0001711) endodermal cell fate specification(GO:0001714) endodermal cell differentiation(GO:0035987) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.2 | 0.7 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.2 | 0.4 | GO:0071397 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.2 | 1.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 2.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 4.8 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.2 | 0.4 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 0.9 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 0.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
0.2 | 0.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.2 | GO:0019374 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.2 | 0.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.8 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.2 | 0.6 | GO:1902624 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.2 | 0.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 1.5 | GO:0098543 | detection of other organism(GO:0098543) |
0.2 | 0.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.4 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 3.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 0.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 2.9 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.2 | 1.8 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.2 | 0.4 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.4 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.2 | 0.6 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.2 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.2 | 0.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 0.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 1.4 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.2 | 2.6 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.2 | 0.2 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.2 | 0.8 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.4 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.2 | 0.8 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.2 | 3.7 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.2 | 0.8 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.2 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 1.0 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.2 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.8 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.2 | 1.7 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 0.2 | GO:0035930 | corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.2 | 0.6 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 0.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.2 | 0.6 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.2 | 0.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.4 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.6 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.2 | 0.7 | GO:0003341 | cilium movement(GO:0003341) |
0.2 | 0.7 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 2.8 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.2 | 0.7 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 0.2 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.2 | 0.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 1.5 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.2 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.5 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.2 | 0.5 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 0.5 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 0.9 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 0.7 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 0.5 | GO:0045007 | depurination(GO:0045007) |
0.2 | 1.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.7 | GO:0033197 | response to vitamin E(GO:0033197) |
0.2 | 0.9 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.2 | 0.5 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 0.4 | GO:0007549 | dosage compensation(GO:0007549) |
0.2 | 5.1 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.2 | 2.5 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.4 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 1.1 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.2 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.3 | GO:0060117 | auditory receptor cell development(GO:0060117) inner ear receptor cell development(GO:0060119) |
0.2 | 0.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 0.3 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 0.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) central nervous system neuron axonogenesis(GO:0021955) |
0.2 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.2 | 1.0 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.2 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.8 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.2 | 0.3 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.2 | 0.2 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.2 | 0.3 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.2 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 1.3 | GO:0006183 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.2 | 0.5 | GO:0070633 | transepithelial transport(GO:0070633) |
0.2 | 0.3 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.2 | 0.3 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 0.7 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.7 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.5 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.2 | 0.8 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.2 | 1.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.8 | GO:0016265 | obsolete death(GO:0016265) |
0.2 | 1.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 1.5 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.2 | 1.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 0.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.2 | 0.5 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.5 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 0.7 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.2 | 0.7 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.5 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.2 | 0.2 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.2 | 0.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.8 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.2 | 1.0 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.2 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.6 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.2 | 1.6 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.2 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 0.2 | GO:0030593 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.2 | 0.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 0.6 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.2 | 0.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 0.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 4.4 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.2 | 0.5 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.2 | 0.2 | GO:0042310 | vasoconstriction(GO:0042310) |
0.2 | 0.3 | GO:0046132 | pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
0.2 | 0.3 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.2 | 0.2 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.2 | 0.8 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.2 | 3.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 0.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.8 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 3.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 0.8 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.2 | 0.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.6 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.5 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.2 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.4 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.3 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 1.8 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.7 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.1 | GO:0072179 | nephric duct formation(GO:0072179) |
0.1 | 1.3 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 0.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.7 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 1.3 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.7 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 1.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.6 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 0.6 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.9 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.1 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.7 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.9 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.7 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.4 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 0.9 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.1 | 1.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 1.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.3 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.1 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.1 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 1.0 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.4 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 3.0 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.4 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.6 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.7 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.1 | 0.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.3 | GO:0001820 | serotonin secretion(GO:0001820) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.4 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 2.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.7 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 1.1 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.1 | 0.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.9 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.5 | GO:0032732 | positive regulation of interleukin-1 production(GO:0032732) |
0.1 | 0.8 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.3 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.1 | 1.1 | GO:0032438 | melanosome organization(GO:0032438) |
0.1 | 0.3 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 3.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 1.6 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.9 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 1.0 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.1 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 0.4 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.1 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.4 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.1 | GO:0072191 | positive regulation of smooth muscle cell differentiation(GO:0051152) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.1 | 0.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 1.1 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 0.4 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 1.6 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 1.9 | GO:0031281 | positive regulation of cyclase activity(GO:0031281) |
0.1 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 2.1 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 0.4 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.1 | 0.7 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 3.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.2 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.6 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.4 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.1 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.2 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.5 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.1 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.2 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 1.7 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.1 | 0.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.8 | GO:0052803 | histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 4.3 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.1 | 3.3 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.1 | 0.4 | GO:0045123 | cellular extravasation(GO:0045123) |
0.1 | 1.4 | GO:0019682 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 0.4 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.1 | 1.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.1 | 0.1 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 2.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.2 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 2.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 13.5 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.6 | GO:0090102 | cochlea development(GO:0090102) |
0.1 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.3 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 1.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.7 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 2.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.4 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.2 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.4 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.4 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.1 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.5 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.9 | GO:0019395 | fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
0.1 | 0.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 19.7 | GO:0006954 | inflammatory response(GO:0006954) |
0.1 | 0.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.6 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.3 | GO:0060487 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.1 | 0.1 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.4 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 1.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.3 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.1 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.1 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.7 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.3 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.2 | GO:0030301 | cholesterol transport(GO:0030301) |
0.1 | 0.2 | GO:0034442 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 1.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 1.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.3 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.1 | 0.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.1 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 1.2 | GO:1903509 | liposaccharide metabolic process(GO:1903509) |
0.1 | 5.5 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.9 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.2 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.1 | 0.2 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.1 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.1 | 0.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 0.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.1 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.1 | 1.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.8 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 0.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 6.9 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.4 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.4 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 1.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.3 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.3 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.3 | GO:0072505 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.1 | 1.2 | GO:0043491 | protein kinase B signaling(GO:0043491) |
0.1 | 0.1 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.1 | 0.1 | GO:0045912 | negative regulation of carbohydrate metabolic process(GO:0045912) |
0.1 | 0.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 1.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.3 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.2 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.1 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 1.5 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.4 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.9 | GO:0015748 | organophosphate ester transport(GO:0015748) phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.3 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.8 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 1.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 2.2 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 0.1 | GO:0003091 | renal water homeostasis(GO:0003091) multicellular organismal water homeostasis(GO:0050891) |
0.1 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.7 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 0.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.2 | GO:0035751 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.4 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 1.5 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 1.0 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.1 | 0.2 | GO:0030258 | lipid modification(GO:0030258) phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.2 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.9 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 2.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.2 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.3 | GO:0051647 | establishment of nucleus localization(GO:0040023) nucleus localization(GO:0051647) |
0.1 | 0.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.5 | GO:0006195 | purine nucleotide catabolic process(GO:0006195) purine-containing compound catabolic process(GO:0072523) |
0.1 | 0.3 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.1 | 0.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.4 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.1 | 0.1 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.1 | 1.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.1 | GO:0015851 | nucleobase transport(GO:0015851) |
0.1 | 0.9 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 1.8 | GO:0042384 | cilium assembly(GO:0042384) cilium organization(GO:0044782) |
0.1 | 0.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.6 | GO:0033865 | coenzyme A metabolic process(GO:0015936) nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.1 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0046083 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.3 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 0.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.1 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 1.9 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.1 | 0.1 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 1.0 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 1.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.4 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.1 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.7 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 0.2 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.3 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 0.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.1 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.3 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 1.0 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.3 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.1 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.1 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.1 | 0.3 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.3 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 0.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.1 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.1 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.3 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 2.1 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.1 | 0.8 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.1 | GO:0051597 | response to methylmercury(GO:0051597) |
0.1 | 0.4 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.1 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.1 | 0.7 | GO:0048017 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.1 | 0.1 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.1 | 0.2 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.1 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.3 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.1 | 0.2 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.1 | 0.1 | GO:0046164 | alcohol catabolic process(GO:0046164) |
0.1 | 0.2 | GO:0021684 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 1.9 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.1 | 0.1 | GO:0001839 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.1 | 0.1 | GO:0003417 | endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) bone growth(GO:0098868) |
0.1 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.2 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.8 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.1 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.1 | GO:0060525 | prostate glandular acinus development(GO:0060525) regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.4 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.1 | 0.3 | GO:0042462 | photoreceptor cell development(GO:0042461) eye photoreceptor cell development(GO:0042462) |
0.1 | 1.4 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.8 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.1 | 0.4 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.1 | 0.2 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.4 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) |
0.1 | 0.7 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.1 | 0.2 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.4 | GO:0098657 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.1 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.2 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.1 | 1.0 | GO:0008366 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
0.1 | 0.1 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.2 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.1 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.1 | 0.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.5 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 1.1 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.1 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 1.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.1 | GO:0034368 | macromolecular complex remodeling(GO:0034367) protein-lipid complex remodeling(GO:0034368) plasma lipoprotein particle remodeling(GO:0034369) |
0.1 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0032965 | regulation of collagen metabolic process(GO:0010712) regulation of collagen biosynthetic process(GO:0032965) regulation of multicellular organismal metabolic process(GO:0044246) |
0.1 | 0.1 | GO:0003044 | regulation of systemic arterial blood pressure by hormone(GO:0001990) regulation of systemic arterial blood pressure mediated by a chemical signal(GO:0003044) |
0.1 | 0.1 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 2.9 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 1.6 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.9 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.8 | GO:0006023 | aminoglycan biosynthetic process(GO:0006023) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.6 | GO:0051318 | G1 phase(GO:0051318) |
0.0 | 0.6 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.2 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.0 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 1.4 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.2 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.0 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.3 | GO:0050906 | detection of stimulus involved in sensory perception(GO:0050906) |
0.0 | 0.8 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 17.3 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 1.8 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 1.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.1 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.0 | 1.0 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 2.8 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.3 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 1.2 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) acetoacetic acid biosynthetic process(GO:0043441) |
0.0 | 0.1 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.0 | 0.1 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 1.5 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 6.4 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 0.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.0 | 0.0 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.2 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.0 | GO:0072205 | collecting duct development(GO:0072044) metanephric collecting duct development(GO:0072205) |
0.0 | 0.3 | GO:0031349 | positive regulation of defense response(GO:0031349) |
0.0 | 0.2 | GO:0006569 | tryptophan metabolic process(GO:0006568) tryptophan catabolic process(GO:0006569) indolalkylamine metabolic process(GO:0006586) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.0 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.0 | 0.5 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.1 | GO:0042402 | amine catabolic process(GO:0009310) cellular biogenic amine catabolic process(GO:0042402) |
0.0 | 0.1 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
0.0 | 0.1 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.4 | GO:0006584 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.3 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.3 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.0 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.0 | 0.2 | GO:0019748 | secondary metabolic process(GO:0019748) |
0.0 | 0.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 3.7 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.1 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
0.0 | 0.4 | GO:0006029 | proteoglycan metabolic process(GO:0006029) |
0.0 | 0.1 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.0 | GO:0048708 | astrocyte differentiation(GO:0048708) |
0.0 | 1.7 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.5 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.0 | GO:2000188 | regulation of growth hormone receptor signaling pathway(GO:0060398) regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.2 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.4 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.0 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.0 | 0.1 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 3.5 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.0 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.0 | 0.1 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 0.2 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
0.0 | 0.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.1 | GO:0006941 | striated muscle contraction(GO:0006941) |
0.0 | 0.1 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.6 | GO:0003015 | heart process(GO:0003015) heart contraction(GO:0060047) |
0.0 | 0.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.9 | GO:0007033 | vacuole organization(GO:0007033) |
0.0 | 0.6 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.0 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.0 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.0 | 0.1 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 1.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0006171 | cAMP biosynthetic process(GO:0006171) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:0061365 | positive regulation of lipoprotein lipase activity(GO:0051006) positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.2 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.0 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 1.0 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
0.0 | 0.0 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.0 | 0.1 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.0 | 0.3 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.0 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 4.4 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 0.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:1901215 | negative regulation of neuron apoptotic process(GO:0043524) negative regulation of neuron death(GO:1901215) |
0.0 | 0.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.1 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.0 | 0.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.2 | GO:0002237 | response to molecule of bacterial origin(GO:0002237) |
0.0 | 0.0 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 0.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) metaphase plate congression(GO:0051310) |
0.0 | 0.0 | GO:0019827 | stem cell population maintenance(GO:0019827) |
0.0 | 0.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.0 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.0 | GO:0042816 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.4 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.0 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.0 | 0.0 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.0 | GO:0002577 | regulation of antigen processing and presentation(GO:0002577) positive regulation of antigen processing and presentation(GO:0002579) |
0.0 | 0.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 1.4 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.0 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.0 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.1 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.1 | GO:0006809 | nitric oxide biosynthetic process(GO:0006809) |
0.0 | 0.0 | GO:0016233 | telomere capping(GO:0016233) |
0.0 | 0.5 | GO:0050954 | sensory perception of mechanical stimulus(GO:0050954) |
0.0 | 0.0 | GO:0014896 | muscle hypertrophy(GO:0014896) |
0.0 | 1.1 | GO:0006897 | endocytosis(GO:0006897) |
0.0 | 0.1 | GO:0048538 | thymus development(GO:0048538) |
0.0 | 0.4 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0032009 | early phagosome(GO:0032009) |
0.6 | 3.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.5 | 2.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 0.5 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.5 | 1.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 3.5 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 1.3 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.4 | 0.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 2.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.4 | 2.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.4 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 1.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.4 | 3.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.4 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 1.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.4 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 1.4 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 1.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 1.5 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 0.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.3 | 3.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 0.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 0.6 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.3 | 0.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 1.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 1.7 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.3 | 2.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 1.4 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 1.1 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 0.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 0.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.3 | 1.6 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.3 | 0.8 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 1.7 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 1.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 2.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 1.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 0.9 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.2 | 1.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 6.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 1.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 0.9 | GO:0001740 | Barr body(GO:0001740) |
0.2 | 1.3 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 1.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 3.6 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 1.3 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.2 | 0.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 1.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 1.8 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 0.6 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.2 | 1.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.2 | 0.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 2.0 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 0.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.2 | 1.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 1.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.2 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 0.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 1.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 5.5 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.2 | 0.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 0.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 0.2 | GO:1990351 | transporter complex(GO:1990351) |
0.2 | 0.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 1.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 2.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.3 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 0.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.9 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 1.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.6 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.1 | 1.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 1.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 2.5 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 1.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 2.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.6 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 0.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 7.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 4.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 1.2 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 1.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.5 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.1 | 1.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 7.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 1.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 1.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.5 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 1.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.1 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.1 | 4.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.6 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.3 | GO:0044437 | vacuolar part(GO:0044437) |
0.1 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.4 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 1.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.2 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 1.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.4 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.6 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 2.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.5 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.5 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.1 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.3 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 6.8 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.8 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.7 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 3.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 5.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.6 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) protein kinase complex(GO:1902911) |
0.1 | 1.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 1.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 4.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.5 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.1 | 0.5 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.7 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.9 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.7 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 0.8 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 8.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 1.0 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 7.1 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.5 | GO:0005844 | polysome(GO:0005844) |
0.1 | 5.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 4.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 4.6 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.1 | 0.8 | GO:0030126 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.1 | 1.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.1 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.1 | 0.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 1.4 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 4.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 1.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 275.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.3 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 0.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.1 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 2.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 2.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.2 | GO:0045277 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) cytochrome complex(GO:0070069) |
0.1 | 0.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.5 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.7 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.2 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.7 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.5 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.5 | GO:0032153 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.0 | 1.2 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.7 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.5 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 3.8 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 1.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 4.5 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 2.0 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 2.0 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.0 | 0.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.2 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.0 | 0.5 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 2.4 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.6 | GO:0030684 | preribosome(GO:0030684) |
0.0 | 0.6 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.0 | GO:0044304 | main axon(GO:0044304) |
0.0 | 0.1 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.0 | 0.4 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 1.2 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 54.0 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.3 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.0 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.1 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 0.4 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.2 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 16.3 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.0 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 11.2 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.3 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.0 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.0 | 0.0 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.0 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 0.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 1.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.5 | GO:0005792 | obsolete microsome(GO:0005792) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0050544 | arachidonic acid binding(GO:0050544) |
1.0 | 3.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.9 | 2.8 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.9 | 3.6 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.9 | 2.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.8 | 2.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.8 | 4.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.8 | 2.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.8 | 2.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.7 | 2.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.6 | 2.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.6 | 1.9 | GO:0050693 | LBD domain binding(GO:0050693) |
0.6 | 5.6 | GO:0019864 | IgG binding(GO:0019864) |
0.6 | 4.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.6 | 1.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.6 | 10.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.6 | 1.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.6 | 1.8 | GO:0004875 | complement receptor activity(GO:0004875) |
0.6 | 1.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.6 | 2.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.6 | 1.7 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.5 | 2.7 | GO:0001846 | opsonin binding(GO:0001846) |
0.5 | 3.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.5 | 1.6 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.5 | 1.6 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.5 | 1.6 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.5 | 2.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 2.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 1.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 3.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.5 | 1.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.5 | 1.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 1.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.5 | 1.4 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.5 | 1.4 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.5 | 1.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 1.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.5 | 1.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.4 | 1.7 | GO:0002054 | nucleobase binding(GO:0002054) |
0.4 | 1.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.4 | 3.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.4 | 1.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 1.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 0.4 | GO:0015440 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.4 | 1.6 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.4 | 1.2 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.4 | 4.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 0.4 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.4 | 2.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.4 | 1.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 2.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 3.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 1.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 3.3 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.4 | 1.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 1.8 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.4 | 5.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.4 | 1.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 1.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 2.5 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.3 | 1.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 1.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 1.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 1.0 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.3 | 1.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 1.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 1.3 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.3 | 1.3 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.3 | 1.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 2.9 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.3 | 0.9 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 2.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 1.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 2.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 1.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 3.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 3.4 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.3 | 3.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 1.4 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.3 | 1.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.3 | 2.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 2.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 0.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.3 | 0.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 3.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 3.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 0.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.3 | 0.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 7.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 0.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 0.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 1.8 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.3 | 0.8 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 0.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 11.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.3 | 1.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 3.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 1.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.5 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 1.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 1.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.7 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 1.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 6.3 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.2 | 2.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 2.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 0.7 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 6.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.7 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.2 | 1.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 1.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 0.7 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 1.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 0.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.7 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.4 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 0.6 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 0.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 2.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 1.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 1.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 1.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.2 | 0.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 5.0 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 0.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.2 | 1.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 1.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 1.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 8.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 1.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 0.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 0.8 | GO:0034979 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent protein deacetylase activity(GO:0034979) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.2 | 1.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 1.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.6 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 1.0 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 0.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 2.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 0.6 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.2 | 2.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 0.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.4 | GO:0016715 | dopamine beta-monooxygenase activity(GO:0004500) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 1.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.8 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 0.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 1.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.2 | 2.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 4.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 2.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 0.6 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.2 | 1.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 2.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 0.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 0.5 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 1.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 0.5 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 0.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.2 | 0.9 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 0.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 1.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 0.2 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.2 | 0.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 3.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 1.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 0.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 4.8 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 1.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.7 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.2 | 1.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.5 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 0.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 7.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.2 | 0.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.2 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 1.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 0.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.7 | GO:0004340 | glucokinase activity(GO:0004340) |
0.2 | 0.2 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.2 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 0.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.3 | GO:0070405 | ammonium ion binding(GO:0070405) |
0.2 | 0.5 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 1.1 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.2 | 0.3 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.2 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 2.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 1.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 34.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.2 | 2.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 1.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.8 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 1.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 3.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.3 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 0.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.4 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.9 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 1.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.3 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 2.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.4 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 1.0 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.3 | GO:0015149 | glucose transmembrane transporter activity(GO:0005355) monosaccharide transmembrane transporter activity(GO:0015145) hexose transmembrane transporter activity(GO:0015149) |
0.1 | 0.1 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 0.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 1.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.5 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 3.3 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 1.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 1.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.4 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.5 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.7 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 1.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.6 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.1 | 0.5 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.3 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 1.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 1.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.5 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.1 | 1.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 1.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 2.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 2.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 1.5 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 0.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.8 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 3.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 1.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 1.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 2.9 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 1.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 1.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 1.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 1.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.4 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.1 | 0.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.6 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.1 | 8.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.4 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.7 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 2.8 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.1 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.5 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 4.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.7 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 1.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 1.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.5 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 1.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.4 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 1.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.1 | 6.0 | GO:0051020 | GTPase binding(GO:0051020) |
0.1 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.4 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 0.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.2 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.7 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.6 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.7 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 1.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.6 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.8 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.1 | 5.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 1.0 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.1 | 1.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.6 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 0.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.6 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.2 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 5.6 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 1.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.3 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 1.3 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 2.0 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 1.4 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 6.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 2.0 | GO:0043492 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) ATPase activity, coupled to movement of substances(GO:0043492) |
0.1 | 0.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 1.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.2 | GO:0016803 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.1 | 0.5 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.1 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.2 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.9 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.1 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.0 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 18.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 1.0 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.4 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 1.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 1.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.4 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.6 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 3.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.0 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.7 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 30.1 | GO:0060089 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 0.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 3.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 4.6 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 7.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.0 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 1.8 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.7 | GO:0001104 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.0 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 1.1 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.0 | 0.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 2.6 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 4.9 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.0 | 0.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) kinase inhibitor activity(GO:0019210) |
0.0 | 0.1 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.0 | 2.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 1.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 1.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 3.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.0 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 1.2 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.8 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.3 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0008144 | drug binding(GO:0008144) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.1 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 0.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.7 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.3 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.0 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 1.1 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.0 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.3 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 2.9 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.0 | 1.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 18.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 17.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 4.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 1.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 4.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 2.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 5.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 2.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 7.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 7.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 2.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 0.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 4.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 6.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 6.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 0.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 2.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 2.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 6.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 1.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 1.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 0.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 4.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 5.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 0.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 1.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 1.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 1.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 4.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 23.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 3.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 2.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 3.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 4.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 3.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 5.2 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.5 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 2.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 2.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.9 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 16.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 3.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 2.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 12.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 1.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 1.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.2 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 1.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 1.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 1.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.2 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 10.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.8 | 9.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.7 | 0.7 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.5 | 2.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 2.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.5 | 6.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 2.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.5 | 1.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.4 | 3.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.4 | 4.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 3.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 5.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.4 | 2.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 0.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.3 | 10.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 1.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 2.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 1.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 1.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.3 | 1.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 4.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 4.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 3.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 3.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 2.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 5.7 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 1.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 0.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 12.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 9.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 0.5 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.2 | 2.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 4.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 0.5 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 4.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 4.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 0.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 6.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 2.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 2.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 2.7 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 2.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 2.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 1.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 3.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 4.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 1.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 0.4 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 2.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 1.3 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.2 | 1.6 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 3.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 2.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 0.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 2.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 4.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 1.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 1.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 1.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 2.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 4.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 2.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 5.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 2.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 7.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 4.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 4.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 2.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 2.9 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.1 | 0.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 1.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 1.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 4.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 3.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 5.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.3 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 10.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 2.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 1.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.2 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 0.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 3.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 4.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 1.0 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 0.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 1.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 2.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 1.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 2.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 5.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 2.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 3.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.6 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 7.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.4 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 4.3 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 13.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 1.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 2.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 1.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 2.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 1.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 1.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |